Analyst Ratings for Iovanace Biotherapeutics (IOVA)
IOVA Rating Summary
IOVA Price Target Summary
- Highest: $18.00 (Wells Fargo)
- Lowest: $7.00 (UBS)
- Average: $12.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.50 (-8.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$12.50 (-8.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Buy (N/A) |
15.00 (N/A) |
10.64 (13.62) |
28.01% | Details |
| 8/22/2026 | TD Cowen » Updated 9/29/2026 |
Nicholas Lorusso | New Coverage | Buy (N/A) |
16.00 (10.00) |
8.99 (13.62) |
51.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
